Liberty Health Sciences (LHS) Pitch Deck (2020) Breakdown

See all 16 slides of the Liberty Health Sciences pitch deck, with a slide-by-slide teardown of what the deck does well and where it falls short.

The July 2020 investor presentation for Liberty Health Sciences (LHS) serves as a status report for a mature, vertically integrated cannabis operator in Florida. Rather than a traditional 'problem-solution' startup pitch, this deck functions as an operational summary for a company that was already profitable as of August 2019 (Slide 2). The deck emphasizes physical infrastructure, citing 387 total acres in Gainesville and a cultivation capacity of 19,500 kg per year (Slide 3). With 26 active dispensaries and 14 more planned, LHS positions itself as a dominant regional player. However, the pro…

Key takeaways

Executive Summary and Operational Overview

The Liberty Health Sciences (LHS) investor presentation from July 2020 is a clinical, data-driven look at a vertically integrated cannabis operator. Unlike early-stage startup decks that spend significant time on the 'why' and the 'problem,' LHS assumes the market opportunity for medical cannabis in Florida is understood. Instead, they focus on their ability to execute at scale, highlighting their infrastructure, production metrics, and retail dominance.

Slide 1: Title Slide

The cover slide establishes the brand identity with the '#LIVEFREE' hashtag and the 'Liberty Health Sciences' logo. The imagery of hands holding a cannabis plant over soil emphasizes the agricultural roots of the business. The date, July 2020, is clearly marked, which is crucial for context in the rapidly evolving cannabis regulatory environment.

Slide 2: Summary

This is the most information-dense slide in the deck, serving as a 'Traction' slide. It lists several key performance indicators (KPIs):

Established: 2017. · Headcount: 300+ team members. · Retail Scale: 26 dispensaries, ranked #4 in Florida, with 14 more upcoming. · Transaction Volume: 50,000+ monthly transactions. · Infrastructure: 115,000 sq. ft. of retail, 190,000 sq. ft. of cultivation, and 50,000 sq. ft. of processing. · Financial Health: Profitable since August 2019. · Compliance: GMP Certified 2020-2021.

By leading with profitability and vertical licensing, LHS immediately separates itself from the 'cash-burn' reputation of many cannabis startups.

Slide 3: Liberty Operations

This slide provides a deep dive into the Gainesville, Florida facility. It breaks down land usage (387 total acres) and production capacity. The inclusion of specific metrics like '40g dry flower yield per plant' and '900 units per hour' for oil filling demonstrates a high level of operational maturity. The retail metrics are equally impressive, noting an average ticket size of $96 and a retail inventory turn of 88%+. This suggests that product is moving through the system quickly, minimizing capital tied up in stock.

Slide 4: Retail Footprint

Slide 4 visualizes the company's market penetration in Florida. It lists 26 dispensary locations and identifies 7 'Hubs' (Dania Beach, Bonita Springs, Merritt Island, Gainesville, Tallahassee, Miami, and St. Petersburg). The map shows a concentration along the coasts and major population centers, illustrating a strategic approach to retail placement that covers the state's most lucrative demographics.

Slide 5: Our Brands

LHS showcases a 'House of Brands' strategy. The slide features internal brands like Zentient and Pretty Pistil alongside well-known third-party brands such as PAX , Mary's Medicinals , Incredibles , and Papa's Herb . This variety suggests that LHS is positioning itself not just as a grower, but as a sophisticated retailer capable of catering to different consumer segments, from value-seekers to premium connoisseurs.

Slide 6: Cultivation

This is a visual transition slide showing the scale of the indoor/greenhouse growing environment. It features young plants under purple LED grow lights and a healthy clone being held, reinforcing the 'science' and 'health' aspects of the company name. It provides visual proof of the 190,000 sq. ft. cultivation space mentioned earlier.

Slide 7: Processing

This slide focuses on the extraction and laboratory side of the business. Images of lab technicians in PPE and distillation equipment highlight the technical complexity of producing cannabis oils and concentrates. This reinforces the 'Vertical Cannabis License' claim, showing they control the value chain from seed to extract.

Slide 8: Manufacturing

The final slide in the provided sequence shows the end-of-line production. It features automated filling of 'Lemon and Grass' branded bottles and packaged 'Zentient' concentrate syringes. This slide completes the narrative of a fully integrated supply chain, showing the transition from raw plant material to a finished, consumer-ready retail product.

What Works in This Deck

Hard Data: LHS avoids vague promises. Every slide is backed by specific numbers—square footage, acreage, units per hour, and transaction counts. For an investor, this level of transparency regarding operational throughput is highly reassuring.

Vertical Integration Story: The deck successfully walks the viewer through the entire lifecycle of the product. By the time you reach Slide 8, you have seen the land, the plants, the lab, and the final packaging. This proves the company isn't reliant on third-party suppliers, which is a major risk-mitigation factor in the cannabis industry.

Profitability: Mentioning profitability on Slide 2 is a powerful hook. In a sector where many companies struggle with 280E tax implications and high overhead, being EBITA positive (or simply 'profitable' as stated) is a major competitive advantage.

What Is Missing

The Team: There is no slide introducing the leadership. In a highly regulated industry like cannabis, the background of the C-suite (legal, agricultural, and retail experience) is critical for investor due diligence.

Financial Projections: While they mention being profitable, the deck lacks a forward-looking financial roadmap. Investors want to see how the addition of the 14 'upcoming' dispensaries will impact the bottom line over the next 12-24 months.

The Ask: The deck does not state how much capital they are looking to raise or what the specific terms of the investment are. This suggests the deck may be used for general investor relations or as a preliminary teaser rather than a formal round-closing tool.

Founder Takeaways

Use 'Proof of Life' Photos: LHS uses high-quality, original photography of their facilities and products. This is far more effective than stock photos of generic cannabis leaves. It proves the assets exist and are operational.

Lead with Traction: If you are profitable or have significant market share (like being #4 in a state), put that on Slide 2. Don't bury your best metrics at the end of the deck.

Quantify Everything: If you claim to have a manufacturing advantage, define it in units per hour. If you claim retail success, define it in inventory turns and ticket size. Specificity builds trust.

Frequently asked questions

What is the primary geographic focus of LHS?
Based on the retail footprint and operations slides, LHS is exclusively focused on the Florida market. Slide 4 shows a map of 26 dispensaries and 7 hubs all located within Florida, and Slide 3 confirms their primary production location is in Gainesville, Florida. They hold a vertical cannabis license specifically for the state of Florida.
Is LHS a profitable company according to this deck?
Yes, Slide 2 explicitly states that the company has been 'Profitable since August 2019.' This is a significant data point for an investor presentation, as it shifts the narrative from speculative growth to operational scaling and sustainability.
How much cannabis can LHS produce annually?
According to Slide 3, the cultivation production capacity is 19,500 kg per year. The facility harvests between 3,500 and 5,000 plants per week, with an average dry flower yield of 40g per plant.
What does the retail operation look like?
LHS operates 26 dispensaries and has 14 more 'coming soon' (Slide 2). They serve over 84,000 patients year-to-date with an average ticket size of $96. Their retail efficiency is high, with an inventory turn rate of over 88% (Slide 3).
What is missing from this investor presentation?
The provided slides lack a management team overview, detailed financial statements (beyond the mention of profitability), a specific funding ask, and a competitive landscape analysis. It functions more as an operational update than a traditional venture capital pitch deck.
Cover slide of the Liberty Health Sciences (LHS) pitch deck — Late Stage / Profitable 2020
Liberty Health Sciences (LHS) pitch deck, slide 1 (2020)

Liberty Health Sciences (LHS) pitch deck: the facts

Company
Liberty Health Sciences (LHS)
Year
2020
Stage
Late Stage / Profitable
Slides
16
Sector
Cannabis / Healthcare
Deck type
Investor Presentation
Outcome
Acquired by Ayr Wellness in 2021 (External Fact)
Headquarters
Gainesville, Florida

Liberty Health Sciences (LHS) pitch deck PDF

The full Liberty Health Sciences (LHS) deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Liberty Health Sciences Inc. (LHS) pitch deck was used for

This is a July 2020 Liberty Health Sciences investor presentation hosted on SlideShare, aligned with the company’s status as a late-stage, profitable, vertically integrated medical cannabis operator in Florida. The deck emphasizes operational scale (cultivation, GMP-certified processing, and a growing dispensary footprint) and profitability achieved by fiscal year 2020. It appears positioned to support ongoing capital markets activity and strategic positioning rather than a single discrete venture round, in the context of Liberty’s public listing on the CSE (LHS) and OTCQX (LHSIF). Later in December 2020, Liberty announced a strategic acquisition by Ayr Strategies (now Ayr Wellness), suggesting that this deck also contributed to framing Liberty’s value for potential strategic buyers.

Business model: Vertically integrated medical cannabis producer and retailer focused on the Florida market, operating cultivation, processing (including GMP‑certified manufacturing), and branded dispensaries under state licensing.

Headquarters
Toronto, Ontario, Canada (corporate); operations focused in Florida, USA.
Industry
Medical cannabis / healthcare

What happened after the Liberty Health Sciences Inc. (LHS) deck

Following the July 2020 investor deck, Liberty Health Sciences continued to grow revenue and achieved positive Adjusted EBITDA, while expanding its Florida dispensary footprint. Later in 2020, the company agreed to be acquired by Ayr Strategies in a stock-for-stock combination valued around US$290 million, effectively transitioning Liberty from an independent late-stage operator into part of a lar

What the Liberty Health Sciences Inc. (LHS) deck got right

What could have been stronger

How an investor would read this deck

What draws attention

Risks that stand out

Questions this deck invites

What founders can take from the Liberty Health Sciences Inc. (LHS) deck

Liberty Health Sciences Inc. (LHS) pitch deck: common questions

What does Liberty Health Sciences (LHS) do?

Liberty Health Sciences Inc. is a vertically integrated medical cannabis company that produces and retails cannabis products in Florida, with cultivation, processing (including GMP-certified manufacturing), and dispensary operations under state licensing.

How large was Liberty Health Sciences’ retail footprint in Florida when this deck was created?

At the time of the July 2020 investor deck, Liberty operated 26 dispensaries across Florida, with additional locations "coming soon" and monthly transaction volumes highlighted as a key metric of retail scale.

Was Liberty Health Sciences profitable around the time of the 2020 investor presentation?

Liberty reported consolidated net sales of approximately C$18.44 million for the quarter ended May 31, 2020, up from C$5.52 million in the prior-year quarter, and positive Adjusted EBITDA of about C$4.58 million, marking a shift to profitability by fiscal year 2020.

What kind of investors was the Liberty Health Sciences 2020 investor deck aimed at?

Liberty Health Sciences was a public company listed on the Canadian Securities Exchange under the ticker LHS and on the OTCQX under LHSIF; its investor presentations were targeted at public market investors, strategic partners, and potential acquirers rather than typical venture capital rounds.

What happened to Liberty Health Sciences after this 2020 investor deck?

On December 22, 2020, Ayr Strategies announced an agreement to acquire Liberty Health Sciences in a stock-for-stock transaction valued at approximately US$290 million, with Liberty shareholders receiving Ayr equity shares according to a fixed exchange ratio.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

Liberty Health Sciences (LHS) pitch deck slides

Liberty Health Sciences (LHS) pitch deck slide 1 of 16
Liberty Health Sciences (LHS) pitch deck — slide 1 of 16
Liberty Health Sciences (LHS) pitch deck slide 2 of 16
Liberty Health Sciences (LHS) pitch deck — slide 2 of 16
Liberty Health Sciences (LHS) pitch deck slide 3 of 16
Liberty Health Sciences (LHS) pitch deck — slide 3 of 16
Liberty Health Sciences (LHS) pitch deck slide 4 of 16
Liberty Health Sciences (LHS) pitch deck — slide 4 of 16
Liberty Health Sciences (LHS) pitch deck slide 5 of 16
Liberty Health Sciences (LHS) pitch deck — slide 5 of 16
Liberty Health Sciences (LHS) pitch deck slide 6 of 16
Liberty Health Sciences (LHS) pitch deck — slide 6 of 16

What each slide of the Liberty Health Sciences (LHS) pitch deck says

Slide 3

SUMMARY EST.2017 GROWING SINCE 2017 TEAM MEMBERS 300+ DISPENSARIES COMING SOON MONTHLY TRANSACTIONS S - o RETAIL IN FLORIDA CULTIVATION IN PROCESSING & GMP CERTIFIED PROFITABLE SINCE VERTICAL CANNABIS s¢ FLORIDA MANUFACTURING 2020-2021 August 2019 LICENSE IN FLORIDA Liberty Health Sciences Inc. is a producer and retailer of cannabis products aimed at improving the quality of peoples' lives.

Slide 4

+ Cancer = pe > Epilepsy fos} =| + Glaucoma ® u 5 + Post-traumatic stress disorder (PTSD) = = » Amyotrophic lateral sclerosis (ALS) » Crohn's disease Baroni rans POPULATION 21,480,000 MARKET DISPENSARIES NO OF ira EST. US $1.6 BILLION STATEWIDE 254 LICENSES 22 » Multiple sclerosis (MS) BY 2022 + Medical conditions of the same kind or class as or comparable to the others listed: es als Se 0 - 5 than the cualified physician issuing the physician BE certification. A= Al + Chronic nonmalignant pain caused by a quailing 6M = ( medical condition or that originates from a qualifying — Ol medical condition and persist beyond the usual course of that qualifying medical condition. QUALIFYING REGISTER…

Slide text above is read directly from the Liberty Health Sciences (LHS) deck PDF embedded on this page.

Related fundraising guides (24)

This deck's categories (1)

Decks from the same year (1)

Decks from the same region (1)

Browse companies alphabetically (1)

Decks in the same category (12)

More pitch deck teardowns (16)

Recently published pitch deck teardowns (12)

Fundraising library · Pitch deck examples · Investor directory · Founder database